The Absence of Diabetic Retinopathy in Patients with Retinitis Pigmentosa: Implications for Pathophysiology and Possible Treatment

Overview

Journal Br J Ophthalmol

Specialty Ophthalmology

Date 2001 Feb 27

PMID 11222350

Citations 64

Authors

G B Arden

Affiliations

Soon will be listed here.

Citing Articles

The Exploration of Disturbance of Capillary and Photoreceptor Communication Networks in Diabetic Retinopathy Through Single-Cell RNA-Seq.

Wang N, Li H, Sun Q, Han X, Su S J Cell Mol Med. 2025; 29(5):e70442.

PMID: 40032635 PMC: 11875770. DOI: 10.1111/jcmm.70442.

Anti-VEGF therapy for proliferative diabetic retinopathy in Kearns-Sayre syndrome.

Leung V, Wong J, Grigg J Doc Ophthalmol. 2024; 150(1):41-46.

PMID: 39729257 DOI: 10.1007/s10633-024-09999-2.

Diabetes Renders Photoreceptors Susceptible to Retinal Ischemia-Reperfusion Injury.

Antonetti D, Lin C, Shanmugam S, Hager H, Cao M, Liu X Invest Ophthalmol Vis Sci. 2024; 65(13):46.

PMID: 39570639 PMC: 11585066. DOI: 10.1167/iovs.65.13.46.

Clinical Evidence of a Photoreceptor Origin in Diabetic Retinal Disease.

Rajagopal R, Kern T Ophthalmol Sci. 2024; 5(1):100591.

PMID: 39328824 PMC: 11426126. DOI: 10.1016/j.xops.2024.100591.

Cellular and Molecular Mechanisms of Neuronal Degeneration in Early-Stage Diabetic Retinopathy.

Callan A, Jha S, Valdez L, Tsin A Curr Vasc Pharmacol. 2024; 22(5):301-315.

PMID: 38693745 DOI: 10.2174/0115701611272737240426050930.

References

Fishman G, Grover S, Jacobson S, Alexander K, Derlacki D, Wu W . X-linked retinitis pigmentosa in two families with a missense mutation in the RPGR gene and putative change of glycine to valine at codon 60. Ophthalmology. 1998; 105(12):2286-96. DOI: 10.1016/S0161-6420(98)91231-3. View

Williams B . A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?. Miner Electrolyte Metab. 1999; 24(6):400-5. DOI: 10.1159/000057401. View

Janecke A, Meins M, Sadeghi M, Grundmann K, Zrenner E, Rosenberg T . Twelve novel myosin VIIA mutations in 34 patients with Usher syndrome type I: confirmation of genetic heterogeneity. Hum Mutat. 1999; 13(2):133-40. DOI: 10.1002/(SICI)1098-1004(1999)13:2<133::AID-HUMU5>3.0.CO;2-U. View

Kucinskas V, Payne A, Ambrasiene D, Jurgelevicius V, Steponaviciute D, Arciuliene J . Molecular genetic study of autosomal dominant retinitis pigmentosa in Lithuanian patients. Hum Hered. 1999; 49(2):71-4. DOI: 10.1159/000022847. View

Bessant D, Payne A, Mitton K, Wang Q, Swain P, Plant C . A mutation in NRL is associated with autosomal dominant retinitis pigmentosa. Nat Genet. 1999; 21(4):355-6. DOI: 10.1038/7678. View

Lu M, Perez V, Ma N, Miyamoto K, Peng H, Liao J . VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci. 1999; 40(8):1808-12. View

Havelius U, Bergqvist D, Falke P, Hindfelt B, KRAKAU T . I. Impaired dark adaptation in symptomatic carotid artery disease. Neurology. 1997; 49(5):1353-9. DOI: 10.1212/wnl.49.5.1353. View

Havelius U, Bergqvist D, Hindfelt B, KRAKAU T . II. Improved dark adaptation after carotid endarterectomy. Evidence of a long-term ischemic penumbra?. Neurology. 1997; 49(5):1360-4. DOI: 10.1212/wnl.49.5.1360. View

Mathews M, Merges C, McLeod D, Lutty G . Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest Ophthalmol Vis Sci. 1998; 38(13):2729-41. View

10.

Buraczynska M, Wu W, Fujita R, Buraczynska K, Phelps E, Andreasson S . Spectrum of mutations in the RPGR gene that are identified in 20% of families with X-linked retinitis pigmentosa. Am J Hum Genet. 1997; 61(6):1287-92. PMC: 1716085. DOI: 10.1086/301646. View

11.

Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I . Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest. 1998; 101(6):1219-24. PMC: 508675. DOI: 10.1172/JCI1277. View

12.

Hammes H, Lin J, Bretzel R, Brownlee M, Breier G . Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes. 1998; 47(3):401-6. DOI: 10.2337/diabetes.47.3.401. View

13.

Mizutani M, Gerhardinger C, Lorenzi M . Müller cell changes in human diabetic retinopathy. Diabetes. 1998; 47(3):445-9. DOI: 10.2337/diabetes.47.3.445. View

14.

Nakazawa M, Wada Y, Tamai M . Arrestin gene mutations in autosomal recessive retinitis pigmentosa. Arch Ophthalmol. 1998; 116(4):498-501. DOI: 10.1001/archopht.116.4.498. View

15.

Cringle S, Yu D, Alder V, Su E, Yu P . Quantification of retinal oxygen consumption changes from preretinal oxygen transients. Aust N Z J Ophthalmol. 1998; 26 Suppl 1:S71-3. DOI: 10.1111/j.1442-9071.1998.tb01379.x. View

16.

Linsenmeier R, Braun R, McRipley M, Padnick L, Ahmed J, Hatchell D . Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci. 1998; 39(9):1647-57. View

17.

Gilbert R, Vranes D, Berka J, Kelly D, Cox A, Wu L . Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest. 1998; 78(8):1017-27. View

18.

Boulton M, Foreman D, Williams G, McLeod D . VEGF localisation in diabetic retinopathy. Br J Ophthalmol. 1998; 82(5):561-8. PMC: 1722605. DOI: 10.1136/bjo.82.5.561. View

19.

Behzadian M, Wang X, Al-Shabrawey M, Shabrawey M, Caldwell R . Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia. 1998; 24(2):216-25. View

20.

Shirao Y, Yamagishi S, Higashide T, Kobayashi M, KATSUNO K, Iyobe A . Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic.... Ophthalmic Res. 1998; 30(6):333-9. DOI: 10.1159/000055493. View